These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18080797)

  • 1. Increased yield of porcine circovirus-2 by a combined treatment of PK-15 cells with interferon-gamma and inhibitors of endosomal-lysosomal system acidification.
    Misinzo G; Delputte PL; Lefebvre DJ; Nauwynck HJ
    Arch Virol; 2008; 153(2):337-42. PubMed ID: 18080797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells.
    Misinzo G; Delputte PL; Nauwynck HJ
    J Virol; 2008 Feb; 82(3):1128-35. PubMed ID: 18032516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased porcine circovirus type 2 replication in porcine leukocytes in vitro and in vivo by concanavalin A stimulation.
    Lefebvre DJ; Meerts P; Costers S; Misinzo G; Barbé F; Van Reeth K; Nauwynck HJ
    Vet Microbiol; 2008 Nov; 132(1-2):74-86. PubMed ID: 18556150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-mediated enhancement of in vitro replication of porcine circovirus type 2 is influenced by an interferon-stimulated response element in the PCV2 genome.
    Ramamoorthy S; Huang FF; Huang YW; Meng XJ
    Virus Res; 2009 Nov; 145(2):236-43. PubMed ID: 19631245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses.
    Kekarainen T; Montoya M; Dominguez J; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):41-9. PubMed ID: 18304652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of porcine circovirus 2 replication in porcine cell lines by IFN-gamma before and after treatment and by IFN-alpha after treatment.
    Meerts P; Misinzo G; Nauwynck HJ
    J Interferon Cytokine Res; 2005 Nov; 25(11):684-93. PubMed ID: 16318582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of different methods to enhance porcine circovirus 2 replication.
    Yang X; Chen F; Cao Y; Pang D; Ouyang H; Ren L
    J Virol Methods; 2013 Feb; 187(2):368-71. PubMed ID: 23159413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine circovirus type 2 stimulates plasmacytoid dendritic cells in the presence of IFN-gamma.
    Baumann A; McCullough KC; Summerfield A
    Vet Immunol Immunopathol; 2013 Dec; 156(3-4):223-8. PubMed ID: 24183591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine circovirus 2 infection of epithelial cells is clathrin-, caveolae- and dynamin-independent, actin and Rho-GTPase-mediated, and enhanced by cholesterol depletion.
    Misinzo G; Delputte PL; Lefebvre DJ; Nauwynck HJ
    Virus Res; 2009 Jan; 139(1):1-9. PubMed ID: 18952130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly permissive subclone of the porcine kidney cell line for porcine circovirus type 2 production.
    Chen HC; Kuo TY; Yang YC; Wu CC; Lai SS
    J Virol Methods; 2013 Feb; 187(2):380-3. PubMed ID: 23219808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of porcine circovirus type 2 infection and replication on activated porcine peripheral blood mononuclear cells in vitro.
    Yu S; Halbur PG; Thacker E
    Vet Immunol Immunopathol; 2009 Feb; 127(3-4):350-6. PubMed ID: 19118906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination.
    Aravindaram K; Kuo TY; Lan CW; Yu HH; Wang PH; Chen YS; Chen GH; Yang NS
    J Gene Med; 2009 Apr; 11(4):288-301. PubMed ID: 19194994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.
    Feng Z; Jiang P; Wang X; Li Y; Jiang W
    Antiviral Res; 2008 Mar; 77(3):186-94. PubMed ID: 18199493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
    Shi K; Li H; Guo X; Ge X; Jia H; Zheng S; Yang H
    Vet Microbiol; 2008 Jun; 129(3-4):367-77. PubMed ID: 18164875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IkappaBalpha degradation.
    Wei L; Kwang J; Wang J; Shi L; Yang B; Li Y; Liu J
    Virology; 2008 Aug; 378(1):177-84. PubMed ID: 18561971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of PK-15 cell lines highly permissive to porcine circovirus 2 infection by transposon-mediated interferon-gamma gene transfer.
    Li Y; Wang Y; Zhou X; Zhang X; Zhang X; Xia X; Sun H
    J Virol Methods; 2019 Sep; 271():113682. PubMed ID: 31216434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine circovirus type 2 displays pluripotency in cell targeting.
    Steiner E; Balmelli C; Herrmann B; Summerfield A; McCullough K
    Virology; 2008 Sep; 378(2):311-22. PubMed ID: 18617215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells--at the front-line of pathogen attack.
    McCullough KC; Ruggli N; Summerfield A
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):7-15. PubMed ID: 19036457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of porcine circovirus type 2 (PCV2) infection in swine lymphocytes using mitogen-stimulated peripheral blood lymphocytes from healthy PCV2-carrier pigs.
    Lin CM; Jeng CR; Chang HW; Guo IC; Huang YL; Tsai YC; Chia MY; Pang VF
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):355-66. PubMed ID: 18554727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.